Rare diseases
Investigational molecules
Locations
Back to Spain549 clinical trials in Zaragoza, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer
SpainStudy on the Long-term Safety and Effects of AL002 and Florquinitau F18 in Patients with Alzheimer's Disease
SpainStudy on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer
SpainStudy Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer
SpainStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
SpainStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate to Severe Plaque Psoriasis
SpainStudy of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer
SpainStudy of BMS-986315 and Nivolumab with Chemotherapy for First-line Treatment in Stage IV or Recurrent Non-Small Cell Lung Cancer Patients
SpainStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
SpainStudy on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment
SpainStudy of LY3819469 for Adults with High Lipoprotein(a) Levels
SpainStudy of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on advanced cancer treatments and blood disorders, including studies of new therapies for lung cancer, pancreatic adenocarcinoma, and various hematologic malignancies.
Multiple trials evaluating combination therapies and novel treatment approaches for both solid tumors and blood cancers.
Research into treatments for various inflammatory and autoimmune disorders, with emphasis on chronic conditions affecting quality of life.
Studies focusing on innovative biological therapies and targeted treatments for inflammatory conditions.
Studies addressing critical cardiovascular health challenges and metabolic conditions, including innovative approaches to stroke treatment and lipid management.
Focus on developing new therapeutic options for both acute and chronic cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
